Descriptive Report of Microorganisms Detected in Cultures of COVID-19 Patients Developing Secondary Infection After Tocilizumab Use
Tocilizumab an anti-inflammatory medication previously approved for the treatment of rheumatoid arthritis, was widely used during the COVID-19 pandemic. Secondary infections following the use of tocilizumab were expected knowing its inhibitory effect on the cascade of inflammation by blocking IL6. P...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Llyfr |
| Cyhoeddwyd: |
Shiraz University of Medical Sciences,
2024-09-01T00:00:00Z.
|
| Pynciau: | |
| Mynediad Ar-lein: | Connect to this object online. |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Rhyngrwyd
Connect to this object online.3rd Floor Main Library
| Rhif Galw: |
A1234.567 |
|---|---|
| Copi 1 | Ar gael |